New York Life Investment Management LLC Vir Biotechnology, Inc. Transaction History

New York Life Investment Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$8.6 - $11.9 $179,456 - $248,317	20,867 Added 140.06%	35,766 $362,000
Q4 2023 Feb 05, 2024	SELL	$7.76 - $10.29 $3,111 - $4,126	-401 Reduced 2.62%	14,899 $149,000
Q3 2023 Nov 07, 2023	SELL	$9.14 - $24.62 $22,036 - $59,358	-2,411 Reduced 13.61%	15,300 $143,000
Q2 2023 Aug 04, 2023	SELL	$23.2 - $27.29 $71,502 - $84,107	-3,082 Reduced 14.82%	17,711 $434,000
Q1 2023 May 08, 2023	BUY	$22.26 - $30.85 $462,852 - $641,464	20,793 New	20,793 $483,000

218

87M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $982M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of New York Life Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on New York Life Investment Management LLC with notifications on news.